Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07159386 · ClinicalTrials.gov registry record · NA
Advanced Fibrosis Detection for MASLD in Primary Care
A NA study, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT07159386 is a NA study that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 225 participants.
The verdict
NCT07159386, a NA study, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will generate generalizable data to dramatically enhance MASLD management in primary care.
Interventions
- OTHER EHR alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2026-03-16 |
| Est. Completion | 2030-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07159386
The ClinicalTrials.gov registry entry for NCT07159386 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EHR alert is the first listed.
NCT07159386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07159386 about?
NCT07159386 is a clinical study titled "Advanced Fibrosis Detection for MASLD in Primary Care". This proposal evaluates the implementation of a novel, non-interruptive, electronic health record alert for metabolic dysfunction-associated steatotic liver disease (MASLD) fibrosis risk assessment in primary care patients with MASLD using a stepped wedge, cluster randomized design. This work will g...
What is the current status of trial NCT07159386?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2026-03-16. Estimated completion is 2030-09.
What interventions are being tested in trial NCT07159386?
The interventions under investigation include: EHR alert (OTHER).
Who is sponsoring clinical trial NCT07159386?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.